Shane Thomas Gleason - 14 Jan 2026 Form 4 Insider Report for InspireMD, Inc. (NSPR)

Role
Chief Commercial Officer
Signature
/s/ Michael Lawless, Attorney-in-Fact for Shane Gleason
Issuer symbol
NSPR
Transactions as of
14 Jan 2026
Net transactions value
$0
Form type
4
Filing time
16 Jan 2026, 18:09:58 UTC
Previous filing
10 Jan 2025
Next filing
02 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gleason Shane Thomas Chief Commercial Officer C/O INSPIREMD, INC., 6303 WATERFORD DISTRICT DRIVE, SUITE 215, MIAMI /s/ Michael Lawless, Attorney-in-Fact for Shane Gleason 16 Jan 2026 0001966214

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NSPR Common Stock Award $0 +453,390 +61% $0.000000 1,200,371 14 Jan 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 14, 2027, January 14, 2028 and January 14, 2029, subject to the Reporting Person's continued service.

Remarks:

Exhibit 24.1: Power of Attorney